The invention relates to combinations of (a) an ATP-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease.
本发明涉及(a)c-abl激酶活性的
ATP竞争性
抑制剂与(b)两种或两种以上其他
抗肿瘤药物的复方制剂,可同时、分别或依次使用,特别是用于延缓增殖性疾病的进展或治疗。